Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults
Nitin Jain(Parul University), Marina Konopleva(Albert Einstein College of Medicine), Keyur P. Patel(The University of Texas MD Anderson Cancer Center), Jörge E. Cortes(Augusta University Health), Steven M. Kornblau(The University of Texas MD Anderson Cancer Center), Jeffrey L. Jorgensen(The University of Texas MD Anderson Cancer Center), Sherry Pierce(The University of Texas MD Anderson Cancer Center), Gloria L. Fawcett(Center for Personalized Cancer Treatment), Deborah A. Thomas(Washington University in St. Louis), Sergej Konoplev(The University of Texas MD Anderson Cancer Center), Debbie Payne-Turner(St. Jude Children's Research Hospital), Kathryn G. Roberts(St. Jude Children's Research Hospital), Charles G. Mullighan(St. Jude Children's Research Hospital), Elias Jabbour(The University of Texas MD Anderson Cancer Center), Agda Karina Eterovic(Center for Personalized Cancer Treatment), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center), Cheryl L. Willman(Mayo Clinic), Kenna Shaw(Center for Personalized Cancer Treatment), Richard C. Harvey(University of New Mexico), Sa A. Wang(Beijing Institute of Technology), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Ken Chen(Center for Personalized Cancer Treatment), I‐Ming Chen(University of New Mexico), Xinyan Lu(University of Southern California), Susan O’Brien(University of California, Irvine), Farhad Ravandi(The University of Texas MD Anderson Cancer Center), Marcus Valentine(St. Jude Children's Research Hospital), Patrick A. Zweidler‐McKay(The University of Texas MD Anderson Cancer Center)
Cited by 385
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k